title: Response to proposed research to reverse brain death: more than regulatory failure.
abstract: In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration between an Indian surgeon, Himanshu Bansal, and a US-based biotech company, Bioquark Inc. The research will be conducted by Bansal's own biotech company, Revita Life Sciences, at his Anupam hospital in Rudrapur, a city in Uttarakhand state.
authors.affiliation: Independent Journalist, 8, Seadoll, 54 Chimbai Road, Bandra West, Mumbai 400 050, India,. sandhya199@gmail.com.
authors.forename: Sandhya
authors.initials: S
authors.lastname: Srinivasan
authors.affiliation: Advocate, 47/1345 MIG Adarsh Nagar Colony, Worli, Mumbai 400 030, India,. courtyardattorneys@gmail.com.
authors.forename: Veena
authors.initials: V
authors.lastname: Johari
mesh_terms: D035843:Biomedical Research / Q000941:ethics* / Q000331:legislation & jurisprudence; D001709:Biotechnology / Q000941:ethics; D001926:Brain Death; D004992:Ethics, Medical; D032984:Ethics, Research; D006761:Hospitals / Q000941:ethics*; D006801:Humans; D007194:India; D015871:Scientific Misconduct / Q000331:legislation & jurisprudence*; D014481:United States